Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ

Plasmodium falciparum

  • Clinical Immunology
    Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria
    Anja Jäschke, Boubacar Coulibaly, Edmond J. Remarque, Hermann Bujard, Christian Epp
  • Open Access
    Vaccines | Spotlight
    N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate
    Shwu-Maan Lee, Chia-Kuei Wu, Jordan L. Plieskatt, Kazutoyo Miura, John M. Hickey, C. Richter King
  • Clinical Immunology | Spotlight
    An Opsonic Phagocytosis Assay for Plasmodium falciparum Sporozoites
    Ryan W. J. Steel, Brandon K. Sack, Moriya Tsuji, Mary Jane L. Navarro, Will Betz, Matt E. Fishbaugher, Erika L. Flannery, Stefan H. I. Kappe
  • VACCINE RESEARCH
    The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert
    Katarina Radošević, Ariane Rodriguez, Angelique A. C. Lemckert, Marjolein van der Meer, Gert Gillissen, Carolien Warnar, Rie von Eyben, Maria Grazia Pau, Jaap Goudsmit
  • VACCINE RESEARCH
    Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In Vitro Growth Inhibition Assay
    Kazutoyo Miura, Hong Zhou, Ababacar Diouf, Samuel E. Moretz, Michael P. Fay, Louis H. Miller, Laura B. Martin, Mark A. Pierce, Ruth D. Ellis, Gregory E. D. Mullen, Carole A. Long
  • MICROBIAL IMMUNOLOGY
    Relationship between Human Immunodeficiency Virus Type 1 Coinfection, Anemia, and Levels and Function of Antibodies to Variant Surface Antigens in Pregnancy-Associated Malaria
    Anthony Jaworowski, Liselle A. Fernandes, Francisca Yosaatmadja, Gaoqian Feng, Victor Mwapasa, Malcolm E. Molyneux, Steven R. Meshnick, Jenny Lewis, Stephen J. Rogerson
  • VACCINE RESEARCH
    Immune Responses of Mice with Different Genetic Backgrounds to Improved Multiepitope, Multitarget Malaria Vaccine Candidate Antigen FALVAC-1A
    S. A. Kaba, A. Price, Z. Zhou, V. Sundaram, P. Schnake, I. F. Goldman, A. A. Lal, V. Udhayakumar, C. W. Todd
  • VACCINE RESEARCH
    Comparative Testing of Six Antigen-Based Malaria Vaccine Candidates Directed Toward Merozoite-Stage Plasmodium falciparum
    David E. Arnot, David R. Cavanagh, Edmond J. Remarque, Alison M. Creasey, Mercy P. K. Sowa, William D. Morgan, Anthony A. Holder, Shirley Longacre, Alan W. Thomas
  • CLINICAL LABORATORY IMMUNOLOGY
    Impact of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine on Antibody Responses to Erythrocytic-Stage Plasmodium falciparum Antigens in Infants in Mozambique
    Diana Quelhas, Laura Puyol, Llorenç Quintó, Elisa Serra-Casas, Tacilta Nhampossa, Eusebio Macete, Pedro Aide, Alfredo Mayor, Inacio Mandomando, Sergi Sanz, John J. Aponte, Virander S. Chauhan, Chetan E. Chitnis, Pedro L. Alonso, Clara Menéndez, Carlota Dobaño
  • MICROBIAL IMMUNOLOGY
    Enzyme-Linked Immunosorbent Assay for Detection of Plasmodium falciparum Histidine-Rich Protein 2 in Blood, Plasma, and Serum
    Carolyne M. Kifude, Halli G. Rajasekariah, David J. Sullivan, V. Ann Stewart, Evelina Angov, Samuel K. Martin, Carter L. Diggs, John N. Waitumbi

Pages

  • Next
  • 1
  • 2
Back to top

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X